NRIX · NASDAQ · Biotechnology

Nurix Therapeutics

Develops protein-degradation medicines through DEL-AI and large-pharma collaborations.

$26.64
After-hours close+0.45 (+1.72%)
At close$26.19(−2.55%)
DateEstimateReportedSurprise
Oct 2026−$0.56
Jul 2026−$0.73−$0.81−11.0%
Apr 2026−$0.76−$0.79−3.9%
Jan 2026−$0.84−$0.82+2.4%
Oct 2025−$0.84−$1.03−22.6%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Jan 2025
Oct 2024
Jul 2024
Apr 2024
Feb 2024
Oct 2023
Jul 2023
Apr 2023
Feb 2023
Oct 2022
Jul 2022
Apr 2022
Jan 2022
Oct 2021
Jul 2021
Apr 2021
Feb 2021
Oct 2020
Jul 2020
May 2020
Nov 2019
Aug 2019
May 2019
Feb 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 8, 2026−$0.56$22.5M
Jul 9, 2026−$0.73−$0.81−11.0%$15.3M$9.0M−40.9%
Apr 8, 2026−$0.76−$0.79−3.9%$14.3M$6.3M−56.1%
Jan 28, 2026−$0.84−$0.82+2.4%$13.4M$13.6M+1.3%
Oct 9, 2025−$0.84−$1.03−22.6%$12.3M$7.9M−35.6%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Jul 9, 2025
Apr 8, 2025
Jan 28, 2025
Oct 11, 2024
Jul 11, 2024
Apr 10, 2024
Feb 15, 2024
Oct 12, 2023
Jul 13, 2023
Apr 13, 2023
Feb 9, 2023
Oct 6, 2022
Jul 7, 2022
Apr 7, 2022
Jan 27, 2022
Oct 14, 2021
Jul 13, 2021
Apr 13, 2021
Feb 16, 2021
Oct 14, 2020
Jul 24, 2020
May 31, 2020
Nov 30, 2019
Aug 31, 2019
May 31, 2019
Feb 28, 2019